TY - JOUR
T1 - Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancer
AU - Itoh, Naoya
AU - Kawabata, Takanori
AU - Akazawa, Nana
AU - Hayakawa, Kayoko
AU - Suzuki, Masahiro
AU - Sakurai, Aki
AU - Uemura, Kohei
AU - Matsumura, Yasufumi
AU - Hase, Ryota
AU - Kato, Hideaki
AU - Hashimoto, Takehiro
AU - Matono, Takashi
AU - van Duin, David
AU - Ohmagari, Norio
AU - Doi, Yohei
AU - Saito, Sho
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026/12
Y1 - 2026/12
N2 - Carbapenem-resistant bacteria represent a significant challenge for patients with cancer; however, the characteristics and prognoses of carbapenem-resistant Gram-negative bacilli (CRGNB) infections in Japanese patients with cancer remain unclear. Therefore, we aimed to investigate the features and outcomes of CRGNB infections in this population. This multicenter prospective observational cohort study prospectively enrolled 167 patients with CRGNB infections, with or without cancer from April 2019 to March 2022. The 30-day mortality rate was numerically higher, although not significantly (18.2% vs. 14.0%, p = 0.45), in the cancer group than in the non-cancer group. The average length of hospital stay was similar (44.6 days vs. 51.0 days, p = 0.55). Similarly, the incidence of the composite outcome—defined as the 30-day mortality or events associated with worsening clinical course—was also not significantly different (56.1% vs. 43.6%, p = 0.12). Propensity score analysis using inverse probability weighting showed no significant difference in the 30-day mortality and average length of hospital stay (p = 0.25 and 0.66). However, the incidence of the composite outcome was significantly higher in the cancer group (odds ratio, 2.36; p = 0.02). Patients with cancer and CRGNB infection experienced worse composite outcomes than those without cancer, highlighting the need for preventive measures for CRGNB infections in this population.
AB - Carbapenem-resistant bacteria represent a significant challenge for patients with cancer; however, the characteristics and prognoses of carbapenem-resistant Gram-negative bacilli (CRGNB) infections in Japanese patients with cancer remain unclear. Therefore, we aimed to investigate the features and outcomes of CRGNB infections in this population. This multicenter prospective observational cohort study prospectively enrolled 167 patients with CRGNB infections, with or without cancer from April 2019 to March 2022. The 30-day mortality rate was numerically higher, although not significantly (18.2% vs. 14.0%, p = 0.45), in the cancer group than in the non-cancer group. The average length of hospital stay was similar (44.6 days vs. 51.0 days, p = 0.55). Similarly, the incidence of the composite outcome—defined as the 30-day mortality or events associated with worsening clinical course—was also not significantly different (56.1% vs. 43.6%, p = 0.12). Propensity score analysis using inverse probability weighting showed no significant difference in the 30-day mortality and average length of hospital stay (p = 0.25 and 0.66). However, the incidence of the composite outcome was significantly higher in the cancer group (odds ratio, 2.36; p = 0.02). Patients with cancer and CRGNB infection experienced worse composite outcomes than those without cancer, highlighting the need for preventive measures for CRGNB infections in this population.
KW - Cancer
KW - Carbapenem-resistant bacteria
KW - Clinical outcomes
KW - Gram-negative bacilli
KW - Japan
KW - Multidrug-resistant infections
UR - https://www.scopus.com/pages/publications/105046216641
UR - https://www.scopus.com/pages/publications/105046216641#tab=citedBy
U2 - 10.1038/s41598-026-54591-0
DO - 10.1038/s41598-026-54591-0
M3 - Article
C2 - 42177260
AN - SCOPUS:105046216641
SN - 2045-2322
VL - 16
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 23572
ER -